HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of two glycoasparagines in the liver in aspartylglycosaminuria.

Abstract
Two water-soluble glycoasparagine storage products were isolated from the liver of a patient with inherited deficiency of lysosomal N-aspartyl-beta-glucosaminidase (aspartylglycosaminuria). The compounds were characterized using gas chromatographic-mass spectrometric analyses of intact and specifically degraded derivatives. The storage compounds were identified as 2-acetamido-1-N-(4'-L-aspartyl)-2-deoxy-beta-D-glucopyranosylamine and alpha-D-mannopyranosyl-(1 leads to 6)-beta-D-mannopyranosyl-(1 leads to 4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1 leads to 4)-2-acetamido-1-N-(4'-L-aspartyl)-2-deoxy-beta-D-glucopyranosylamine. Their amounts in the pathological liver were approximately 2.7 mg/g and 0.2 mg/g, wet weight, respectively. These glycoasparagines are structurally related to the inner core region of a number of different glycoproteins.
AuthorsP Maury
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 254 Issue 5 Pg. 1513-5 (Mar 10 1979) ISSN: 0021-9258 [Print] United States
PMID762149 (Publication Type: Journal Article)
Chemical References
  • Glycopeptides
  • Oligosaccharides
  • glycoasparagines
  • Asparagine
Topics
  • Asparagine (analogs & derivatives, metabolism)
  • Chromatography, Gas
  • Glycopeptides (metabolism)
  • Humans
  • Liver (metabolism)
  • Mass Spectrometry
  • Mucolipidoses (metabolism)
  • Oligosaccharides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: